Arbutus Biopharma (ABUS) Interest Coverage Ratio (2013 - 2026)
Arbutus Biopharma (ABUS) posted quarterly Interest Coverage Ratio of 7343.83 for Q1 2026, up 900.14% year-on-year from 734.28 in Q1 2025, and up 77147.7% on a QoQ basis from 9.53 in Q4 2025.
Arbutus Biopharma (ABUS) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Arbutus Biopharma (ABUS) has reported Interest Coverage Ratio for 14 consecutive years, with 7343.83 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio rose 900.14% year-over-year to 7343.83 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6802.04 (up 1178.06% YoY) and the FY2025 annual result came in at 0.21, up 51.64% from the prior year.
- Interest Coverage Ratio rose to 7343.83 in Q1 2026 per ABUS's latest filing, from 9.53 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for ABUS reached as high as 7343.83 in Q1 2026 and fell as low as 917.82 in Q1 2025.
- A 5-year average of 197.21 and a median of 107.51 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio slumped 1721.76% — and 2026, when it jumped 900.14%.
- Year by year, Interest Coverage Ratio stood at 29.07 in 2022, then sank by 1721.76% to 471.52 in 2023, then climbed by 1.5% to 464.43 in 2024, then jumped by 97.95% to 9.53 in 2025, then jumped by 77147.7% to 7343.83 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 7343.83, 9.53, and 376.48 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | 7,343.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,343.83 |
| Dec 31, 2025 | -9.53 |
| Sep 30, 2025 | -376.48 |
| Jun 30, 2025 | 53.14 |
| Mar 31, 2025 | -917.82 |
| Dec 31, 2024 | -464.43 |
| Sep 30, 2024 | -739.31 |
| Jun 30, 2024 | -222.51 |
| Mar 31, 2024 | -115.26 |
| Dec 31, 2023 | -471.52 |
| Sep 30, 2023 | -468.65 |
| Jun 30, 2023 | -107.51 |
| Mar 31, 2023 | -87.94 |
| Dec 31, 2022 | 29.07 |
| Sep 30, 2022 | -41.52 |
| Jun 30, 2022 | -29.27 |
| Mar 31, 2022 | -21.69 |
| Dec 31, 2021 | 12.63 |
| Sep 30, 2021 | -24.16 |
| Jun 30, 2021 | -24.43 |